PT-141, also known as Bremelanotide, is a melanocortin receptor agonist that works through the central nervous system to stimulate sexual desire directly in the brain. Unlike treatments that only address blood flow, PT-141 targets the neurological pathway behind arousal itself, making it effective for both men and women across a wide range of sexual health concerns including low libido, reduced arousal, and difficulty with desire that does not respond to hormonal or vascular treatments alone.
